About
About Sihuan Pharmaceutical Holdings Group Ltd
Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People's Republic of China, the United States, and internationally. It operates in three segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. The company offers filling, shaping, supporting, supplementing, optoelectronic devices, body sculpturing, skin care, and other services, as well as non- or minimally invasive comprehensive medical aesthetics solutions. It also provides drugs for cardio-cerebral vascular, digestive system, anti-infective, metabolism, respiratory, neurology, oncology, diabetes, and other indications, as well as modern Chinese medicine and industrial hemp products. In addition, the company offers general hospital services. Sihuan Pharmaceutical Holdings Group Ltd. was founded in 2001 and is based in Wan Chai, Hong Kong.
Research context
Sihuan Pharmaceutical Holdings Group Ltd appears in PyInvesting’s Hong Kong Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- HKD
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Visit company website
5 years, 6 months ago
Sihuan Pharmaceutical Holdings Group Ltd is currently in a long term uptrend where the price is trading 48.5% above its 200 day moving average.
From a valuation standpoint, the stock is 93.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.9.
Sihuan Pharmaceutical Holdings Group Ltd's total revenue rose by 15.1% to $1B since the same quarter in the previous year.
Its net income has increased by 144.1% to $323M since the same quarter in the previous year.
Finally, its free cash flow grew by 91.3% to $-44M since the same quarter in the previous year.
Based on the above factors, Sihuan Pharmaceutical Holdings Group Ltd gets an overall score of 5/5.